NCAM1 and neoplasm: The elevated NK-T (CD3+ CD16+ CD56+) and NK (CD3- CD16+ CD56+) cell populations in the patient AA-1 (Table 2) suggest that these innate effector cells may also have participated in the protection of tumor-recurrence in this patient.